This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Forastiero, R R Articles by de Larrañaga, G F Search for Related Content PubMed PubMed Citation Articles by Forastiero, R R Articles by de Larrañaga, G F Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies

Division of Haematology, Thrombosis and Haemostasis, Favaloro University, Favaloro Foundation, forastiero{at}favaloro.edu.ar

M E Martinuzzo

Division of Haematology, Thrombosis and Haemostasis, Favaloro University, Favaloro Foundation

G F de Larrañaga

Section of Biochemistry, Thrombosis and Haemostasis, Hospital of Infectious Diseases FJ Muñiz, Buenos Aires, Argentina

The antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL) in patients with thromboembolic complications. In APS, most aPL are autoantibodies to ß₂-glycoprotein I and prothrombin, which play a major role in the APS pathogenesis. Nevertheless, antibodies with the same antigen specificity are also found in aPL patients with leprosy, in whom thromboembolic complications are uncommon. The in vivo upregulation of the tissue factor (TF) pathway and the imbalance of cytokines have been proposed as potential mechanisms of thrombosis in the APS. We measured the circulating levels of TF, interleukin 6 (IL-6), IL-6 receptor (sIL-6R), tumor necrosis factor (TNF-a) and interferon g (IFN-g) in 83 patients with autoimmune aPL (42 with and 41 without clinical features of definite primary APS), 48 leprosy patients (33 with aPL) and 48 normal controls. There was a trend (P = 0.06) to higher median sTF in patients with autoimmune aPL (139 pg/mL) compared with leprosy patients (103.5 pg/mL) and controls (123 pg/mL). In addition, the frequency of raised sTF levels (.187 pg/mL) was significantly higher in the group with autoimmune aPL [22.9% (APS 21.4%, non-APS 24.4%)] but not in leprosy (10.4%) compared with controls (4.2%). Elevated levels of IL-6 and TNF-a and a trend to lower IFN-g were found in patients with definite APS. Leprosy patients with aPL, however, had increased TNF-a and IFN-g but normal IL-6 levels. Levels of sIL-6R did not differ between controls and either patients with autoimmune aPL or leprosy. The different cytokine profiles as well as differences in circulating levels of TF might contribute to the high thrombotic risk found in patients with autoimmune aPL but not in leprosy related aPL patients.

Key Words: antiphospholipid syndrome • leprosy • proinflammatory cytokines • tissue factor

Lupus, Vol. 14, No. 2, 129-136 (2005)
DOI: 10.1191/0961203305lu2048oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Z. Romay-Penabad, M. G. Montiel-Manzano, T. Shilagard, E. Papalardo, G. Vargas, A. B. Deora, M. Wang, A. T. Jacovina, E. Garcia-Latorre, E. Reyes-Maldonado, et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo Blood, October 1, 2009; 114(14): 3074 - 3083. [Abstract] [Full Text] [PDF]

				P. R. J. Ames, I. Antinolfi, A. Ciampa, J. Batuca, G. Scenna, L. R. Lopez, J. Delgado Alves, L. Iannaccone, and E. Matsuura Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease? Rheumatology, December 1, 2008; 47(12): 1832 - 1837. [Abstract] [Full Text] [PDF]

				E. M. Egorina, M. A. Sovershaev, J. O. Olsen, and B. Osterud Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer Blood, February 1, 2008; 111(3): 1208 - 1216. [Abstract] [Full Text] [PDF]

				C Hamid, K Norgate, D P D'Cruz, M A Khamashta, M Arno, J D Pearson, G Frampton, and J J Murphy Anti-{beta}2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome Ann Rheum Dis, August 1, 2007; 66(8): 1000 - 1007. [Abstract] [Full Text] [PDF]

				R. A Asherson, S. S Pierangeli, and R. Cervera Is there a microangiopathic antiphospholipid syndrome? Ann Rheum Dis, April 1, 2007; 66(4): 429 - 432. [Full Text] [PDF]